Publications
Found 8 results
Filters: Keyword is Humans and Author is Benoît Stijlemans [Clear All Filters]
"High affinity nanobodies against the Trypanosome brucei VSG are potent trypanolytic agents that block endocytosis.",
PLoS Pathog, vol. 7, issue 6, pp. e1002072, 2011 Jun.
"The central role of macrophages in trypanosomiasis-associated anemia: rationale for therapeutical approaches.",
Endocr Metab Immune Disord Drug Targets, vol. 10, issue 1, pp. 71-82, 2010 Mar.
"Current status of vaccination against African trypanosomiasis.",
Parasitology, vol. 137, issue 14, pp. 2017-27, 2010 Dec.
"Scrutinizing the mechanisms underlying the induction of anemia of inflammation through GPI-mediated modulation of macrophage activation in a model of African trypanosomiasis.",
Microbes Infect, vol. 12, issue 5, pp. 389-99, 2010 May.
"African trypanosomosis: from immune escape and immunopathology to immune intervention.",
Vet Parasitol, vol. 148, issue 1, pp. 3-13, 2007 Aug 19.
"Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor.",
Nat Med, vol. 12, issue 5, pp. 580-4, 2006 May.
"[Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor].",
Med Sci (Paris), vol. 22, issue 11, pp. 914-6, 2006 Nov.
"VSG-GPI anchors of African trypanosomes: their role in macrophage activation and induction of infection-associated immunopathology.",
Microbes Infect, vol. 4, issue 9, pp. 999-1006, 2002 Jul.